What is the Epclusa Patient Assistance Program?
Patient Assistance Programs for Epclusa Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program. Provider: Support Path Patient Assistance Program
How much does Epclusa cost per co-pay?
99% of Medicaid patients taking EPCLUSA or its Authorized Generic pay $5 or less per co-pay. 3,a Patients who are dual-eligible may be covered through their Medicare benefit and pay $9.85 or less per co-pay. 4 8 out of 10 Medicare patients taking EPCLUSA or its Authorized Generic pay $15 or less for the full course of treatment. 2,b
Are all calls with Epclusa educators confidential?
All calls with EPCLUSA Educators are completely confidential and private. Nurse support does not take the place of talking with your Hep C Specialist. If you’ve been diagnosed with Hep C, you can get the personalized support you deserve.
What are the risks of taking Epclusa?
This may cause serious liver problems including liver failure and death. If you are at risk, your healthcare provider will monitor you during and after taking EPCLUSA. What should I tell my healthcare provider before taking EPCLUSA?
What is the support PATH program?
Support Path® is a program that can help patients get started on Gilead and Asegua treatments. Support Path Program Navigators can help you understand your insurance coverage and identify potential financial support options based on your circumstances, insurance, and eligibility criteria for programs.
Does insurance pay for Epclusa?
Epclusa is usually covered by most commercial health insurance plans, Medicare, and some Medicaid plans. Coverage may require prior authorization. The out-of-pocket expense, however, will depend on the insurance plan's formulary, deductibles, and coinsurance.
What is Gilead Access Program?
Gilead's Advancing Access program helps patients understand their coverage and identify financial support options to access their Gilead HIV treatment, HIV prevention medication and COVID-19 medication Veklury®, remdesivir.
Who is the manufacturer of Epclusa?
Epclusa is manufactured and marketed by Gilead Sciences, Inc., of Foster City, California.
What is the average cost of Epclusa?
The cost of Epclusa (sofosbuvir and velpatasvir) tablets is roughly $US78,078 for a full 12-week course of treatment. Your cost might vary based on insurance or manufacturer-provided discounts. Epclusa is covered by most insurance plans. For more information, see Epclusa Prices, Coupons and Patient Assistance Programs.
How much does Epclusa cost in US?
The cost for Epclusa oral pellet (150 mg-37.5 mg) is around $26,250 for a supply of 28 pellet, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
What is Prepdap?
PrEP DAP (Pre-Exposure Prophylaxis Drug Assistance Program) is a drug assistance program for HIV-negative people who have risk factors that expose them to HIV. PrEP DAP Brochure (English)(PDF) About PrEP DAP, an HIV prevention program for people that are at high risk of HIV.
What is ViiV connect?
What Is ViiVConnect? ViiVConnect provides comprehensive information to help healthcare professionals, pharmacists, patient representatives, and patients explore ways to access prescribed ViiV Healthcare medications.
Does Gilead copay card expire?
Have no fear, the cards are not expired, and you can still fill your PrEP prescription. Gilead has updated their RxBIN, RxPCN, RxGRP, and anyone who previously had a 9-digit Member ID now has a new 11 digit Member ID. This can be done while you're at the pharmacy.
What does Epclusa do to your body?
Generic Name: sofosbuvir-velpatasvir These drugs work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer.
Is there a generic version of Epclusa?
In January 2019, Asegua Therapeutics, a subsidiary of Gilead Sciences, launched authorized generic versions of Gilead's Epclusa (velpatasvir/sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) tablets. Generic Epclusa was launched January 7, 2019 and generic Harvoni will launch late January.
How do you feel after Hep C treatment?
Since hepatitis C doesn't always cause any symptoms, you may not feel any different after being cured. If you were experiencing symptoms — fatigue is the common one — you should start to feel stronger and more energetic, which should continue to improve after you finish treatment, says Massoud.
What tier is Epclusa?
Medicare prescription drug plans typically list sofosbuvir / velpatasvir on Tier 5 of their formulary. Generally, the higher the tier, the more you have to pay for the medication.
Can I get Mavyret free?
You may be eligible to receive free MAVYRET if you: Have been prescribed MAVYRET. Have limited or no health insurance coverage. Live in the United States.
What can I take for heartburn while on Epclusa?
Omeprazole (Prilosec®) no more than 20 mg daily is okay. Esomeprazole (Nexium®), lansoprazole (Prevacid®), rabeprazole (Aciphex®), and pantoprazole (Protonix®) have not been studied with Epclusa®. Do not take supplements or tea containing St. John's wort while taking Epclusa ®.
What should I tell my healthcare provider before taking EPCLUSA?
Tell your healthcare provider about all of your medical conditions, including if you have ever had hepatitis B infection, liver problems other than hepatitis C infection, or a liver transplant; if you have kidney problems or are on dialysis; if you have HIV; or if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed. It is not known if EPCLUSA will harm your unborn baby or pass into your breast milk.
What is EPCLUSA?
EPCLUSA is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype 1-6 infection with or without cirrhosis (compensated).
What are the side effects of epclua?
The most common side effects of EPCLUSA include headache and tiredness. The most common side effects of EPCLUSA when used with ribavirin in adults with decompensated cirrhosis are tiredness, low red blood cells, nausea, headache, trouble sleeping, and diarrhea.
Does epclua cause headaches?
The most common side effects of EPCLUSA in adults include headache and tiredness. The most common side effects of EPCLUSA when used with ribavirin in adults with decompensated cirrhosis are tiredness, low red blood cells, nausea, headache, trouble sleeping, and diarrhea.
What is the dosage of EpclUSA?
EPCLUSA (sofosbuvir 400 mg/velpatasvir 100 mg, 200 mg/50 mg tablets; 200 mg/50 mg, 150 mg/37.5 mg oral pellets) is indicated for the treatment of patients 3 years of age and older with chronic hepatitis C virus (HCV) genotype 1-6 infection without cirrhosis or with compensated cirrhosis and in combination with ribavirin for those with decompensated cirrhosis.
How much does EPCLUSA cost?
Help patients register for a co-pay coupon. Commercial patients may pay as little as $15 for a full course of EPCLUSA or its Authorized Generic
What are the adverse reactions to EPCLUSA?
The most common adverse reactions (≥10%, all grades) with EPCLUSA were headache and fatigue; and when used with RBV in decompensated cirrhotics were fatigue, anemia, nausea, headache, insomnia, and diarrhea.
What is the endpoint of SVR12?
Sustained virologic response (SVR12) was the primary endpoint for all clinical trials and was defined as HCV RNA <15 IU/mL at 12 weeks after the end of treatment.
Is EPCLUSA a generic?
With EPCLUSA and its Authorized Generic, you have access for the majority of your insured HCV patients.
How much does a commercial patient pay for a copay?
Commercial patients may pay as little as $5 per co-pay for their medicine. Patients are not eligible if they are enrolled in a government healthcare prescription drug program such as Medicare Part D or Medicaid (including patients who are in the Medicare coverage gap known as the “donut hole”).
Is the Real-World Integrated Analysis presented in the EPCLUSA?
The Real-World Integrated Analysis is not presented in the EPCLUSA full Prescribing Information.
What is the dosage of EpclUSA?
EPCLUSA (sofosbuvir 400 mg/velpatasvir 100 mg, 200 mg/50 mg tablets; 200 mg/50 mg, 150 mg/37.5 mg oral pellets) is indicated for the treatment of patients 3 years of age and older with chronic hepatitis C virus (HCV) genotype 1-6 infection without cirrhosis or with compensated cirrhosis and in combination with ribavirin for those with decompensated cirrhosis.
What are the adverse reactions to EPCLUSA?
The most common adverse reactions (≥10%, all grades) with EPCLUSA were headache and fatigue; and when used with RBV in decompensated cirrhotics were fatigue, anemia, nausea, headache, insomnia, and diarrhea.
Can hepatitis B be reactivated with EPCLUSA?
BOXED WARNING: RISK OF HEPATITIS B VIRUS REACTIVATION IN HCV/HBV COINFECTED PATIENTS Test all patients for evidence of current or prior hepatitis B virus (HBV) infection before initiating treatment with EPCLUSA. HBV reactivation has been reported in HCV/HBV coinfected patients who were undergoing or had completed treatment with HCV direct-acting antivirals (DAAs) and were not receiving HBV antiviral therapy. Some cases have resulted in fulminant hepatitis, hepatic failure, and death. Cases have been reported in patients who are HBsAg positive, in patients with serologic evidence of resolved HBV, and also in patients receiving certain immunosuppressant or chemotherapeutic agents; the risk of HBV reactivation associated with treatment with HCV DAAs may be increased in patients taking these other agents. Monitor HCV/HBV coinfected patients for hepatitis flare or HBV reactivation during HCV treatment and post-treatment follow-up. Initiate appropriate patient management for HBV infection as clinically indicated.
Who was excluded from the ASTRAL pivotal trial?
Patients who were active injection drug users (use within 12 months), or those with a positive urine drug test at screening, were excluded from the ASTRAL pivotal trials.
Can you take epclusa with phenobarbital?
Coadministration of EPCLUSA is not recommended with proton-pump inhibitors, phenobarbital, phenytoin, rifabutin, rifapentine, efavirenz, and tipranavir/ritonavir due to decreased concentrations of sofosbuvir and/or velpatasvir.
What is Epclusa used for?
Epclusa (sofosbuvir/velpatasvir) is a member of the antiviral combinations drug class and is commonly used for Hepatitis C.
Is Epclusa valid with insurance?
Prices are for cash paying customers only and are not valid with insurance plans. A generic version of Epclusa is available, see sofosbuvir/velpatasvir prices.
